Highlights from the journal CHEST^®, August 2022

August 10, 2022

Glenview, Illinois – Published monthly, the journal CHEST^® features peer-reviewed, cutting-edge original research in chest medicine: Pulmonary, critical care and sleep medicine and related disciplines. Journal topics include asthma, chest infections, COPD, critical care, diffuse lung disease, education and clinical practice, pulmonary vascular disease, sleep, thoracic oncology and the humanities.

The August issue of CHEST journal contains 47 articles, including clinically relevant research, reviews, case series, commentary and more. Each month, the journal also offers complementary web and multimedia activities, including visual abstracts, to expand the reach of its most interesting, timely and relevant research.

“This month’s issue has many great articles warranting a callout. One I would like to personally highlight is, ‘Provider Perspectives on and Access to Palliative Care for Patients With Interstitial Lung Disease,’ that looks at barriers to palliative care (PC) in interstitial lung disease (ILD),” says Editor in Chief of the journal CHEST, Peter Mazzone, MD, MPH, FCCP. “Despite the documented benefits of palliative care in ILD, this research shows availability of PC services is often fragmented and varies depending on caregiver practice and geographic location. For more articles focusing on equity within medicine, the journal CHEST has a dedicated topic collection that can be found here.”

Also included in the current issue of the journal CHEST:

• COPD
  Original research, “ Optimizing COPD Acute Care Patient Outcomes Using a Standardized Transition Bundle and Care Coordinator,” finds that the transition bundle reduced 7- and 30-day hospital readmissions but increased length of stay and emergency department revisits. A visual abstract for this research can be viewed here, and an animation of the research can be viewed here.
• Critical Care
  “ Targeted Temperature Management After In-Hospital Cardiac Arrest: An Ancillary Analysis of Targeted Temperature Management for CardiacArrest With Nonshockable Rhythm Trial Data” signaled that more patients had good neurological outcomes when managed with targeted temperature management (33 °C) versus targeted normothermia (37 °C). A visual abstract for the research can be viewed here, and a podcast of experts discussing the research can be found here.

• Humanities
  Exhalations article, “The Vexing Voyage of Vasopressin: The Consequences of Granting Market Exclusivity to Unapproved Drugs,” looks at the use of vasopressin during the COVID-19 pandemic to call attention to the perils of granting market exclusivity as a regulatory incentive.

• Pulmonary Vascular
  Looking at the “obesity paradox” in pulmonary arterial hypertension, “BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension” found that higher BMI did not modify the treatment response for change in 6-minute walk distance but did attenuate the treatment response for functional class defined by the World Health Organization.

To view the entire August issue of the CHEST journal, visit journal.chestnet.org, and follow @journal_CHEST on Twitter for the latest journal news.

About the American College of Chest Physicians

The American College of Chest Physicians^® (CHEST) is the global leader in the prevention, diagnosis and treatment of chest diseases. Its mission is to champion advanced clinical practice, education, communication and research in chest medicine. It serves as an essential connection to clinical knowledge and resources for its 19,000+ members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For information about the American College of Chest Physicians, and its flagship journal CHEST^®, visit chestnet.org.